| Ribbon Retractor Market Size to Reach USD 991 Million by 2031 | Key Trends & Growth Insights |
|
| Global Ribbon Retractor Market
is witnessing accelerated expansion, reaching USD 565 million in 2024
and projected to climb to USD 991 million by 2031, reflecting a strong CAGR
of 8.6%. This growth trajectory is supported by rising surgical proced |
| read more |
|
|
| COX-2 ELISA Kit Market Size to Reach USD 17.5 Million by 2031 | |
|
| Global Prostaglandin-endoperoxide
Synthase 2 (COX-2) ELISA Kit market is poised for sustained expansion,
reaching USD 17.5 million by 2031, up from USD 10.7 million in 2024,
reflecting a steady CAGR of 7.5%. This growth is driven by rising demand
|
| read more |
|
|
| 1.5T Helium-Free MRI System Market Poised to Reach USD 1.38 Billion by 2031 |
|
| Global 1.5T helium-free MRI
system market is experiencing accelerated momentum as healthcare organizations
shift toward sustainable diagnostic imaging technologies. The market, valued at
USD 959 million in 2024, is projected to grow to USD 1,010 m |
| read more |
|
|
| Lazy Eye Market Size to Reach USD 6.82 Billion by 2032 | Key Trends & Forecasts |
|
| Global Lazy Eye market is
entering a transformational growth phase driven by early childhood screening
initiatives, rapid advancements in digital therapeutics, and increasing
availability of personalized vision treatment platforms. Valued at USD 3 |
| read more |
|
|
| Metastases Spinal Tumor Market Size to Reach USD 1.40 Billion by 2032 | Key Trends & Forecasts |
|
| Global Metastases Spinal Tumor
market continues to demonstrate steady expansion driven by rising cancer
prevalence, advancements in non-invasive therapies, and increased focus on
precision oncology. Valued at USD 1,085 million in 2024, the market |
| read more |
|
|
| Mitochondrial Myopathies Market Size to Reach USD 49.2 Million by 2032 | |
|
| Global Mitochondrial Myopathies
market is entering a new phase of strategic transformation, fueled by
precision diagnostics, rare disease awareness, and advancements in targeted
therapeutics. Valued at USD 28.1 million in 2024, the market is
proj |
| read more |
|
|
